Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

ClinicalTrials.gov ID: NCT06152042

Public ClinicalTrials.gov record NCT06152042. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 1:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 2 Randomized, Double-blind Trial of BMF-219 Compared to Placebo in Participants With Type 1 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.

Study identification

NCT ID
NCT06152042
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biomea Fusion Inc.
Industry
Enrollment
37 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 27, 2023
Primary completion
May 19, 2025
Completion
Jul 17, 2025
Last update posted
Aug 27, 2026

2023 – 2025

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Oceanic Research Group North Miami Beach Florida 33169
Lucas Research, Inc. Morehead City North Carolina 28577
Alliance for Multispecialty Research, LLC. Norman Oklahoma 73069
University Diabetes & Endocrine Consultants Chattanooga Tennessee 37411
Velocity Clinical Research Dallas Texas 75230
Texas Diabetes & Endocrinology Round Rock Texas 78681
Diabetes & Glandular Disease Clinic, P.A. San Antonio Texas 78229
Consano Clinical Research, LLC Shavano Park Texas 78231
Manassas Clinical Research Center Manassas Virginia 20110

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06152042, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 27, 2026 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06152042 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →